New York morning headlines


If this email is not displayed correctly, please click on the following link or open your browser and
paste the link into the address field: http://view.ed4.net/v/73UJGG/PNW5BN/97WJHH5/KEOMFH/

Financial Times
beyondbrics



New York headlines

* Eurozone edges back into growth in July

* iPhone sales boost Apple shares

* Jindal brothers vie for control of Stemcor's Indian assets

* China divides wheat bulls and bears

* GSK reviews commission policy for sales staff in China

* China bans construction of government buildings for 5 years

* Thai billionaire plans infrastructure IPO

* Gulf oil producers benefit from falling Iran sales

* Investor alarm as India flashes amber

* Turkey rate rise highlights emerging markets dilemma

* IMF: sorry Argentina, you are on your own afterall

Markets: mixed

Eurozone edges back into growth in July
The eurozone edged back into growth territory in July, according to the initial estimate of a leading business survey that will be seized on as evidence the bloc could finally exit the recession that it fell into in early 2012.
http://on.ft.com/1dUsSh7

iPhone sales boost Apple shares
Apple countered concerns that the best years of smartphone growth were behind it, as iPhone sales beat expectations, despite a sharp drop in third-quarter earnings.
http://on.ft.com/13b5ozw

Jindal brothers vie for control of Stemcor's Indian assets
Two of India's most high-profile industrial tycoons, brothers Naveen and Sajjan Jindal, are vying to buy the iron ore assets of Stemcor, the private British steel trading group.
http://on.ft.com/1dSRt6f

China question divides wheat bulls and bears
It is the million dollar question that is dividing wheat bulls and bears at the moment: how much grain will China need to import? The US Department of Agriculture wrongfooted the markets by more than doubling its forecasts for Chinese wheat imports for the 2013-14 crop year from 3.5m tonnes to 8m tonnes.
http://on.ft.com/12LathP

GSK reviews commission policy for sales staff in China
GlaxoSmithKline is considering cutting prescription-linked commissions paid to its sales staff and reducing drug prices in China amid the fall-out from a growing corruption probe.
http://on.ft.com/1aGwL9K

China bans construction of government buildings for 5 years
China has banned the construction of government offices for the next five years, ratcheting up an austerity campaign that has already taken a toll on the economy. The State Council, China's cabinet, and the Communist party late Tuesday said the ban, which takes immediate effect, would also apply to the expansion of existing buildings.
http://on.ft.com/142hYr1

Thai billionaire plans infrastructure IPO
Thailand's richest man, Dhanin Chearavanont, is turning to the country's volatile stock market to refinance his debt-laden telecoms group and raise money to build out a 3G mobile network in the country.
http://on.ft.com/17ADQXy

Gulf oil producers benefit from falling Iran sales
Gulf oil producers are benefiting from the sharp fall in crude exports from Iran through increased export revenues, according to analysis by the US government's Energy Information Administration.
http://on.ft.com/1c08Bsk

Investor alarm as India flashes amber
The rains fall fast during India's annual monsoon season. Unfortunately for the country's government, the rupee has fallen just as quickly. The Reserve Bank of India responded last week with a slate of measures to trim liquidity, aiming to stop further tumbles in a currency that has dipped around 10 per cent since May, hitting repeated all-time lows.
http://on.ft.com/19fW3he

Turkey rate rise highlights emerging markets dilemma
Turkey's decision to raise its overnight lending rate for the first time in nearly two years underscores the dilemma facing developing economies as the end to US monetary easing draws near: focus on inflation or growth?
http://on.ft.com/12g9340

IMF: sorry Argentina, you are on your own afterall
Never a dull moment with the Argentina-holdouts debt saga. The latest twist comes courtesy of the US Treasury. After apparently egging on the IMF to file an amicus brief in support of Argentina's appeal for a US Supreme Court hearing (not in support of Argentina, you understand, but in order to raise concerns about the systemic risk and potential damage to be done to future sovereign restructurings), it suddenly pulled its support.
http://on.ft.com/1c1q43T

Emerging Markets
MSCI Emerging Market Index up +0.15% at 970.45

Europe
FTSE down +0.88% at 6,655
RTS down -0.56% at 1,372
Warsaw Wig up +0.03% at 46,729
FTSE 300 Eurotop up +0.87% at 1,218

Americas
DJIA up +0.14% at 15,568
S&P 500 down -0.19% at 1,692
Bovespa up +0.51% at 48,820

Asia
Nikkei 225 down -0.32% at 14,731
Topix down -0.23% at 1,220
Hang Seng up +0.24% at 21,969
Shanghai Composite down -0.52% at 2,033
MSCI Asia ex-Japan up +0.17% at 447.74
CNX Nifty down -1.44% at 5,991

Currencies
€/$ 1.32 (1.32)
$/¥ 99.97 (99.44)

Commodities
Brent Crude (ICE) down -0.52 at 107.90
Light Crude (Nymex) unchanged 0.00 at 107.23
100 Oz Gold (Comex) up +5.90 at 1,341

Advertisement

Tools
Your account Portfolio
Email Briefings Price alerts
Keyword alerts RSS feeds
© THE FINANCIAL TIMES LTD 2009
ABOUT THIS EMAIL You have received this email because you have signed up from the NBE preference page on FT.com
Change Briefings UnsubscribeChange Email AddressForward this email to a friendPrivacy Policy About UsHelp
The Financial Times Limited, registered in England and Wales number 227590. Registered office: Number One Southwark Bridge, London SE1 9HL. VAT number GB 278 5371 21.